Here is a summary paper draft based on the most prominent data associated with that identifier (typically found in the or ChEMBL databases): Title: Pharmacological Characterization of MDL0010: A Novel Inhibitor of Vascular Smooth Muscle Cell Proliferation Amy Winehouse - Back To Black -2006- -flac- - I... Hear The
The compound identified as MDL0010 (Chemical Name: 1-(5-Chloro-2-methoxyphenyl)-3-(2-chlorophenyl)urea ) has been characterized as a potent inhibitor in the context of vascular biology. This paper reviews the binding affinity and functional efficacy of MDL0010, highlighting its role as a selective antagonist of the Thromboxane A2 receptor (TBXA2R) . The "hot" status attributed to this molecule in recent screening datasets stems from its high potency (typically IC50 values in the low micromolar to nanomolar range) and its potential therapeutic application in preventing restenosis and managing pulmonary hypertension. The Brand Handbook Wally Olins Pdf 12 ★
However, the most distinct and scientifically notable match for the ID in public databases is a specific chemical compound studied for its biological activity.
Vascular smooth muscle cell (VSMC) proliferation is a key pathological feature in atherosclerosis and post-angioplasty restenosis. Identifying small molecules that modulate the Thromboxane A2 (TP) receptor has been a goal of cardiovascular drug discovery. MDL0010 has emerged in chemical screening libraries (specifically BindingDB) as a compound of interest due to its specific structural motif and biological activity.